Data collected by nine population-based tumor registries participating in the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute were analyzed to characterize the epidemiology of noncarcinoid adenocarcinomas of the colon and rectum in young adults. Tumors diagnosed in ...
A retrospective review of all the 951 patients less than 40 years of age with colorectal cancer in Denmark 1943–67 is described. The annual incidence
colon cancer in patients 40 years old or younger:患者40岁或更年轻的结肠癌,colon cancer in patients 40 years old or younger:患者40岁或更年轻的结肠癌,colon,ca..
Colon cancer is the third most common cancer in the U.S. Get the facts on colon cancer (colorectal cancer) signs, symptoms, causes, prognosis, treatment, and prevention screening through colonoscopy.
The aim of this study was to evaluate the potential impact of tumor size on the long-term outcome of colon cancer (CC) patients after curative surgery. A total of 782 curatively resected T4a stage CC patients without distant metastasis were enrolled. Patients were categorized into 2 groups acc...
Solid cancers exhibit a dynamic balance between cell death and proliferation ensuring continuous tumour maintenance and growth1,2. Increasing evidence links enhanced cancer cell apoptosis to paracrine activation of cells in the tumour microenvironment in
reasonable to enquire whether the nature of the activities of this microflora may influence the risk of malignancy in the colorectal area. It is further relevant to ask to what extent dietary factors, which may influence the risk of colon cancer, may act through, or be modulated by, the ...
2. Age for colon cancer trending younger (under age 50) In contrast to falling or steady rates of colorectal cancer incidence in older adults, a concerning trend is the rising occurrence of young people (< 50 years old) with colorectal cancer. Simply blaming obesity and diabetes in this popu...
1 In node-positive colon cancer, adjuvant chemotherapy is generally recommended. In contrast, the benefit in stage II cancers is minimal, and the decision of whether to use an adjuvant therapy depends on additional risk factors.2 Insufficient lymph node harvest is one of these factors.3 However...
The CG-758 colon cancer cell line and its autologous B-lymphoblastoid cell line (LCL-758) were previously described.1 Both lines were established from primary human tissues provided by Boehringer Ingelheim (Vienna, Austria) and obtained from a patient who provided informed consent under a research...